Neuromuscular HOMEepAGE
neuromuscular.wustl.edu
/
A–Z

Granulomatous Myopathies

MitochondrialImmune/AntibodyOMIM 600031
W
View full entry on WUSTL Neuromuscular
antibody/infmyop.htm#Granulomatous Myopathies 132

Overview

From WUSTL Neuromuscular

Clinical features Weakness: Proximal; Dysphagia Muscle hypertrophy: Occasional Progression: Slow; Occasionally acute with pain Post-menopausal females Some patients with progressive flexion contractures of arms Treatment Corticosteroids: Benefit General: 40% to 80% More likely: Associated systemic sarcoidosis Less likely: Isolated granulomatous myopathy; IBM-like clinical syndrome Laboratory Serum CK: Normal or High Aldolase: ? More often elevated than CK Pathology Granulomas Non-caseating Giant cells Some biopsies Multinucleated CHIT1 staining 147 Location in muscle Endomysium or Perimysial c

OMIM Entries

OMIM #600031

Related Conditions

Shared genes
Asymmetric Myopathic Weakness
VAMP
Finger Flexion Weakness
VAMP
Immune & Inflammatory Myopathies: Neoplasm Associations
VPVAMP
Inclusion Body Myositis (IBM)
VAMPIADRB1
Inflammatory & Immune Myopathies (IIM): Acquired
RNAVAMPINCLUSION
Inflammatory Myopathy + Mitochondrial Pathology in muscle (IM-Mito), subtype of IM-VAMP
VAMP
Muscle Fiber Pathology
VPSRPVAMP
Other Muscle Features
VAMPINCLUSIONBCIM

External Resources

WUSTL Neuromuscular
Washington University Disease Center
OMIM
Online Mendelian Inheritance in Man
PubMed
Biomedical Literature
GeneReviews
NCBI Expert-Authored Reviews
Orphanet
Portal for Rare Diseases
NORD
National Organization for Rare Disorders

Data sourced from the Washington University Neuromuscular Disease Center. For clinical use, always refer to primary sources.